Therapeutics: Programmed cell death 1 (PD-1; PDCD1; CD279); asparagine-linked glycosylation 8 (ALG8); laminin α subunit 4 (LAMA4); ADP-dependent glucokinase (AD

Cancer

INDICATION: Cancer

Two studies in mice suggest tumor vaccines based on tumor-specific mutant antigens could help improve the efficacy of therapies targeting PD-1 and other checkpoint

Read the full 256 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE